Live News EQUITY FLASH L impact Oct 27, 2026, 12:23 PM UTC Capitainer Begins Clinical Sampling for HbA1c FDA Study Capitainer said clinical sampling has begun for its HbA1c FDA 510(k) study. SquawkNews Desk